Breastfeeding

ELVIE PUTS MATERNAL SUPPORT UNDER A MICROSCOPE WITH NEW REPORT

Retrieved on: 
Tuesday, April 9, 2024

NEW YORK, April 9, 2024 /PRNewswire/ -- Today, Elvie, the disruptive global FemTech health and wellness brand, releases "The Motherload: The weight of limited postpartum support," their first-ever report, in partnership with Mother.ly, putting the state of maternal health under the microscope. The study of over 1,000 women with children has uncovered a trio of serious pregnancy and postpartum challenges that mothers currently face. 

Key Points: 
  • As a female-founded and female-grounded company, Elvie has worked tirelessly to empower women through radical female-first technology that harnesses their incredible biology.
  • "With this new research, we're demonstrating something those mothers already know: postpartum care in the US is simply not good enough."
  • Only 28% say they had good mental health during the postpartum period, but only 31% had professional mental health support.
  • While mothers understand that postpartum challenges are guaranteed, they're often complicated by a lack of strong structural support and poor paid maternity leave policies.

CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China

Retrieved on: 
Monday, January 22, 2024

[See *Correction above: The TR-4 Return Pad is not approved for use by the U.S. Food & Drug Administration.]

Key Points: 
  • [See *Correction above: The TR-4 Return Pad is not approved for use by the U.S. Food & Drug Administration.]
  • "The approval of Thermage FLX, and the TR-4 return pad, marks a significant milestone for Solta Medical," Thomas J. Appio, Bausch Health Chief Executive Officer, said.
  • "The approval from NMPA means we are able to continue the momentum of the growth of Thermage in China," Jiny Kim, Senior Vice President, Solta Medical, said.
  • Ask your doctor for more information about Thermage FLX and see www.thermage.com for additional details.

Human medicines European public assessment report (EPAR): Quofenix, delafloxacin, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024

Human medicines European public assessment report (EPAR): Quofenix, delafloxacin, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Quofenix, delafloxacin, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

CorMedix Inc. Announces Partnership With The Leapfrog Group

Retrieved on: 
Monday, December 4, 2023

BERKELEY HEIGHTS, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced an agreement with The Leapfrog Group, an independent national watchdog organization of employers and other purchasers focused on health care safety, whereby CorMedix Inc. will become a member of the Leapfrog Partners Advisory Committee.

Key Points: 
  • As a Leapfrog partner, CorMedix will advise the Leapfrog board and management on industry and policy trends and help shape the organization’s long-term strategic vision.
  • “An alliance between The Leapfrog Group and CorMedix brings together two organizations both focused on a common goal: improving patient safety and quality of care across the U.S. healthcare system,” said Joseph Todisco, Chief Executive Officer, CorMedix.
  • “CorMedix is dedicated to developing solutions that reduce the risk of healthcare associated infections, in particular catheter-related bloodstream infections (CRBSIs).
  • Every American deserves the highest quality health care, and together with CorMedix we can achieve our shared vision for excellence,” said Leah Binder, Leapfrog president and CEO.

BoobieJuice supports Breast Feeding Awareness Month in August

Retrieved on: 
Tuesday, August 1, 2023

BoobieJuice turns frozen breast milk into a freeze dried breast milk powder, making the ease and use of a formula with Mom's very own breast milk.

Key Points: 
  • BoobieJuice turns frozen breast milk into a freeze dried breast milk powder, making the ease and use of a formula with Mom's very own breast milk.
  • BoobieJuice pouches make breast milk much easier for child care, travel and final night bottle feeds.
  • With the excitement of Breast Feeding Awareness Month, BoobieJuice has partnered with two events in August.
  • This event is held to support breast feeding Moms and includes a beautiful group photo of local women breast feeding their children with the background of the Arizona scenery.

Expensive dental care worsens inequality. Is it time for a Medicare-style 'Denticare' scheme?

Retrieved on: 
Sunday, July 2, 2023

Private dental care is increasingly unaffordable, and millions of Australians go without the treatment they need.

Key Points: 
  • Private dental care is increasingly unaffordable, and millions of Australians go without the treatment they need.
  • The potentially avoidable costs to the health-care system and to people’s quality of life has led to increased pressure for a Medicare-style universal insurance scheme for dental care (Denticare) or the inclusion of dental care into Medicare.
  • Affordable and available dental care is crucial to addressing inequality in Australia.

Why wasn’t dental included in Medicare in the first place?

    • There is, however, little to no evidence on the extent to which the Whitlam government pushed for dental to be included or how much it was opposed by dentists.
    • It seems it was not on the agenda when Medicare was restored by the Hawke government.
    • Secondly, the provision of public dental health services – often linked to dental hospitals and dental schools – has long been seen (especially by Coalition governments) as the responsibility of states and territories.

A short history

    • This section gives the Commonwealth the power to legislate and fund these services but it’s not obligated to do so.
    • The Whitlam government was the first to provide national funding and direction to these state-based programs through the Australian School Dental Program.

The barriers to universal dental care

    • These figures don’t factor in the savings made to health-care costs due to preventable dental cavities and gum disease (estimated by the Australian Dental Association at $818 million per year) and reduced productivity.
    • The other approach is to reduce costs by limiting the number of people covered and/or the number and type of services covered.
    • Means testing access to Medicare Benefits Schedule items for dental care is risky; it could easily lead to means testing of access to other MBS items.

There’s more we can do

    • Researchers have described the Chronic Dental Disease Scheme (introduced by the Howard government) as as “the most expensive and controversial public dental policy in Australian history”.
    • As a 2012 analysis showed, it blew out its budget and did not result in dental health improvements.
    • It’s worth noting many of the preventive actions needed to address obesity (for example, encouraging breast feeding and limiting sugary beverages) will also improve dental health.
    • Read more:
      How to fill the gaps in Australia's dental health system

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

Retrieved on: 
Thursday, February 23, 2023

SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM), announced today that its Board of Directors has unanimously approved a comprehensive strategic process to explore and evaluate strategic alternatives to maximize shareholder value.

Key Points: 
  • SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM), announced today that its Board of Directors has unanimously approved a comprehensive strategic process to explore and evaluate strategic alternatives to maximize shareholder value.
  • Evofem is the provider of Phexxi, the first and only FDA-approved hormone-free, woman-controlled contraceptive gel that women use on demand.
  • Potential strategic alternatives to be explored or evaluated as part of this process may include, but are not limited to, a merger, reverse merger, other business combination, sales of assets, licensing or other strategic transactions involving the Company.
  • Evofem does not expect to disclose developments with respect to this process unless until the evaluation of strategic alternatives has been completed or the Board of Directors has concluded disclosure is appropriate or legally required.

Smart for Life Ramps Up Manufacturing of Milk Dust Lactation Products During Baby Formula Scarcity

Retrieved on: 
Thursday, June 23, 2022

Milk Dust has partnered with Smart for Life to manufacture its proprietary products designed to support mothers breast milk production since 2019.

Key Points: 
  • Milk Dust has partnered with Smart for Life to manufacture its proprietary products designed to support mothers breast milk production since 2019.
  • The Milk Dust line of products was founded and created by a mom of four, who wanted to help other mothers keep their milk supply while getting back in shape.
  • Milk Dust satisfies sugar cravings with clean, nutrient-dense protein that is made specifically for postpartum healing, nourishment, lactation, and is designed to help mothers bring back their pre-pregnancy figure.
  • The Milk Dust lactation protein powder offers proprietary, patent-pending lactation and protein blend to help breastfeeding mothers.

Advisory - Dr. pen microneedling devices are not authorized for sale and may pose health risks

Retrieved on: 
Thursday, December 16, 2021

Issue: These devices are not authorized and may pose health risks.

Key Points: 
  • Issue: These devices are not authorized and may pose health risks.
  • Health Canada assesses the devices for their safety, quality and effectiveness before issuing medical device licences to authorize their sale.
  • In addition, to date, no microneedling devices have been authorized for at-home use, where there are higher health risks associated with inappropriate use, contamination, and infection.
  • Report adverse effects or complaints involving medical devices, including the sale of unauthorized devices, to Health Canada.

Cerebelly, the Science-Backed Children's Food Brand, Launches Protein-Packed, Nutrient-Dense Bone Broth Puree Pouches

Retrieved on: 
Thursday, October 28, 2021

Nothing the human brain is fully developed by five years old, the pouches focus on the amino acids delivered through animal protein in addition to the 16 nutrients already found in Cerebelly's existing pouches.

Key Points: 
  • Nothing the human brain is fully developed by five years old, the pouches focus on the amino acids delivered through animal protein in addition to the 16 nutrients already found in Cerebelly's existing pouches.
  • "We created these Bone Broth pouches to help familiarize your children with a range of flavors while also keeping the 16 nutrients and proteins in each pouch, making mealtime easier for parents all around.
  • Each bone broth pouch is formulated for babies, but suitable for all ages.
  • Organic, non-GMO, vegetable-first, dairy-free, gluten-free, with no added sugar, Cerebelly's brain-supporting non-BPA pouches contain 16 brain-supporting nutrients (8x the amount of nutrients compared to the 7 top-selling baby food brands).